Economic Burden of Eosinophilic Esophagitis: A Nationwide Cost-of-Illness Study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 38775961.
- Also identified by DOI 10.14309/ajg.0000000000002868.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite its increasing prevalence, the economic impact of eosinophilic esophagitis (EoE) is understudied. We estimated the societal economic burden of EoE by using real-world data from Swedish health registers. Patients with EoE had 45% higher societal cost ($6,290 vs $4,349) compared with the general population, primarily driven by increased healthcare costs ($2,414 vs $1,022), which accounted for 72% of the excess societal cost in EoE. EoE is associated with a considerable economic burden to society. With the prevalence of EoE still rising, the economic burden of EoE is expected to continue to grow.
Medical subject headings
- Eosinophilic Esophagitis
- Cost of Illness
- Health Care Costs